The EU-AIMS Longitudinal European Autism Project (LEAP): Design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders

Molecular Autism

Volumn 8, Issue 1, 2017, Pages

  Loth, Eva ^a   Charman, Tony ^a   Mason, Luke ^b   Tillmann, Julian ^a   Jones, Emily J H ^b   Wooldridge, Caroline ^a   Ahmad, Jumana ^a   Auyeung, Bonnie ^c,d   Brogna, Claudia ^e   Ambrosino, Sara ^f   Banaschewski, Tobias ^g   Baron Cohen, Simon ^c   Baumeister, Sarah ^g   Beckmann, Christian ^h   Brammer, Michael ^a   Brandeis, Daniel ^g,i   Bölte, Sven ^j   Bourgeron, Thomas ^k   Bours, Carsten ^h   De Bruijn, Yvette ^h   Chakrabarti, Bhismadev ^c,l   Crawley, Daisy ^a   Cornelissen, Ineke ^h   Acqua, Flavio Dell' ^a   Dumas, Guillaume ^k   Durston, Sarah ^f   Ecker, Christine ^a,m   Faulkner, Jessica ^a   Frouin, Vincent ⁿ   Garces, Pilar ^o   Goyard, David ⁿ   Hayward, Hannah ^a   Ham, Lindsay M ^o   Hipp, Joerg ^o   Holt, Rosemary J ^c   Johnson, Mark H ^b   Isaksson, Johan ^j,p   Kundu, Prantik ^q   Lai, Meng Chuan ^c,r   D'Ardhuy, Xavier Liogier ^o   Lombardo, Michael V ^c,s   Lythgoe, David J ^a   Mandl, René ^f   Meyer Lindenberg, Andreas ^g   Moessnang, Carolin ^g   Mueller, Nico ^g   O'Dwyer, Laurence ^h   Oldehinkel, Marianne ^h   Oranje, Bob ^f   Pandina, Gahan ^t   Persico, Antonio M ^e,u   Ruigrok, Amber N V ^c   Ruggeri, Barbara ^a   Sabet, Jessica ^a   Sacco, Roberto ^e   Cáceres, Antonia San José ^a   Simonoff, Emily ^a   Toro, Roberto ^k   Tost, Heike ^g   Waldman, Jack ^c   Williams, Steve C R ^a   Zwiers, Marcel P ^h   Spooren, Will ^o   Murphy, Declan G M ^a   Buitelaar, Jan K ^h   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^h RADBOUD UNIVERSITY   (Netherlands)

ⁱ UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^j KAROLINSKA INSTITUTE   (Sweden)

^k INSTITUT PASTEUR   (France)

^l UNIVERSITY OF READING   (United Kingdom)

^m UNIVERSITY HOSPITAL FRANKFURT   (Germany)

ⁿ DIF   (France)

^o F HOFFMANN LA ROCHE LTD   (Switzerland)

^p UPPSALA UNIVERSITY   (Sweden)

^q MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF TORONTO   (Canada)

^s UNIVERSITY OF CYPRUS   (Cyprus)

^t JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^u UNIVERSITY OF MESSINA   (Italy)

more..

Author keywords

Biomarkers; Cognition; EEG; Eye tracking; Genetics; MRI; Neuroimaging

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; AUTISM; BRAIN FUNCTION; CHILD; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC RISK; GENOMICS; HUMAN; INTELLECTUAL IMPAIRMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; BRAIN; CHEMISTRY; CLASSIFICATION; CLINICAL TRIAL; DIAGNOSTIC IMAGING; GENETIC HETEROGENEITY; GENETICS; HAIR; INDIVIDUALITY; MULTICENTER STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULOGRAPHY; PATHOPHYSIOLOGY; PATIENT SELECTION; PERSONALIZED MEDICINE; PHENOTYPE; PROCEDURES; SALIVA; SIBLING;

ADULT; AUTISM SPECTRUM DISORDER; BIOMARKERS; BRAIN; CHILD; EYE MOVEMENT MEASUREMENTS; FEMALE; GENETIC HETEROGENEITY; HAIR; HUMANS; INDIVIDUALITY; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; PATIENT SELECTION; PHENOTYPE; PRECISION MEDICINE; SALIVA; SIBLINGS;

EID: 85021086460     PISSN: None     EISSN: 20402392     Source Type: Journal    
DOI: 10.1186/s13229-017-0146-8     Document Type: Article

References (117)

1. Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61:1-19.
2. Kanner L. Autistic disturbances of affective contact. Nerv Child. 1943;2:217-50.
3. Asperger H. Die "Autistischen Psychopathen" im Kindesalter. Archiv fuer Psychiatrie und Nervenkrankheiten. 1944;117:76-136.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (Fifth ed.). Arlington: American Psychiatric Publishing; 2013.
5. Charman T. Variability in neurodevelopmental disorders: evidence from autism. In: Riby D, Van Herwegen J, editors. Applied Research and Key Issues in Neurodevelopmental Disorders. Routledge Psychology Press; 2015. p. 117-40.
6. Charman T, Jones CR, Pickles A, Simonoff E, Baird G, Happe F. Defining the cognitive phenotype of autism. Brain Res. 2011;1380:10-21.
7. Bourgeron T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci. 2015;16:551-63.
8. Sahin M, Sur M. Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders. Science. 2015;350:921-9.
9. Geschwind DH. Advances in autism. Annu Rev Med. 2009;60:367-80.
10. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11:126.
11. Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES, Munafo MR. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14:365-76.
12. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.
13. Ioannidis JP. How to make more published research true. PLoS Med. 2014;11:e1001747.
14. Murphy D, Spooren W. EU-AIMS: a boost to autism research. Nat Rev Drug Discov. 2012;11:815-6.
15. Loth E, Spooren W, Murphy DG, Consortium E-A. New treatment targets for autism spectrum disorders: EU-AIMS. Lancet Psychiatry. 2014;1:413-5.
16. Lai MC, Lombardo MV, Auyeung B, Chakrabarti B, Baron-Cohen S. Sex/gender differences and autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry. 2015;54:11-24.
17. Bolte S, Willfors C, Berggren S, Norberg J, Poltrago L, Mevel K, Coco C, Fransson P, Borg J, Sitnikov R, et al. The roots of autism and ADHD twin study in Sweden (RATSS). Twin Res Hum Genet. 2014;17:164-76.
18. Loth E, Spooren W, Ham LM, Isaac MB, Auriche-Benichou C, Banaschewski T, Baron-Cohen S, Broich K, Bolte S, Bourgeron T, et al. Identification and validation of biomarkers for autism spectrum disorders. Nat Rev Drug Discov. 2016;15:70-3.
19. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47:921-9.
20. Wong AY, Hsia Y, Chan EW, Murphy DG, Simonoff E, Buitelaar JK, Wong IC. The variation of psychopharmacological prescription rates for people with autism spectrum disorder (ASD) in 30 countries. Autism Res. 2014;7:543-54.
21. Frazier TW, Shattuck PT, Narendorf SC, Cooper BP, Wagner M, Spitznagel EL. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011;21:571-9.
22. Rutter M, Caspi A, Moffitt TE. Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies. J Child Psychol Psychiatry. 2003;44:1092-115.
23. Lord C, Petkova E, Hus V, Gan W, Lu F, Martin DM, Ousley O, Guy L, Bernier R, Gerdts J, et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch Gen Psychiatry. 2012;69:306-13.
24. Constantino JN, Hudziak JJ, Todd RD. Deficits in reciprocal social behavior in male twins: evidence for a genetically independent domain of psychopathology. J Am Acad Child Adolesc Psychiatry. 2003;42:458-67.
25. Hartman CA, Luteijn E, Serra M, Minderaa R. Refinement of the Children's Social Behavior Questionnaire (CSBQ): an instrument that describes the diverse problems seen in milder forms of PDD. J Autism Dev Disord. 2006;36:325-42.
26. Bodfish JW, Symons FJ, Parker DE, Lewis MH. Varieties of repetitive behavior in autism: comparisons to mental retardation. J Autism Dev Disord. 2000;30:237-43.
27. Evans DW, Uljarevic M, Lusk LG, Loth E, Frazier T. Development of two new dimensional measures of restricted and repetitive behaviors in parents and children. J Am Acad Child Adolesc Psychiatry. 2017;56(1):51-8.
28. Tomchek SD, Dunn W. Sensory processing in children with and without autism: a comparative study using the short sensory profile. Am J Occup Ther. 2007;61:190-200.
29. Ausderau K, Sideris J, Furlong M, Little LM, Bulluck J, Baranek GT. National survey of sensory features in children with ASD: factor structure of the sensory experience questionnaire (3.0). J Autism Dev Disord. 2014;44:915-25.
30. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31:5-17.
31. Baron-Cohen S, Hoekstra RA, Knickmeyer R, Wheelwright S. The autism-spectrum quotient (AQ) - adolescent version. J Autism Dev Disord. 2006;36:343-50.
32. Goodman R, Ford T, Richards H, Gatward R, Meltzer H. The development and well-being assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology. J Child Psychol Psychiatry. 2000;41:645-55.
33. Sparrow S, Cicchetti DV, Balla DA: Vineland adaptive behavior scales. 2nd ed.Circle Pines, MN: American. Guidance Service Inc.; 2005
34. Bird HR, Shaffer D, Fisher P, Gould MS, Staghezza B, Chen JY, Hoven C. The Columbia-Impairment-Scale (Cis) - pilot findings on a measure of global impairment for children and adolescents. Int J Methods Psychiatr Res. 1993;3:167-76.
35. Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol. 2007;17:103-11.
36. Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003;2:255-67.
37. Baron-Cohen S, Leslie A, Frith U. Does the autistic child have a "theory of mind"? Cognition. 1985;21:37-46.
38. Begeer S, Bernstein DM, van Wijhe J, Scheeren AM, Koot HM. A continuous false belief task reveals egocentric biases in children and adolescents with autism spectrum disorders. Autism. 2012;16:357-66.
39. Senju A, Southgate V, White S, Frith U. Mindblind eyes: an absence of spontaneous theory of mind in Asperger syndrome. Science. 2009;325:883-5.
40. Abell F, Happe F, Frith U. Do triangles play tricks? Attribution of mental states of animated shapes in normal and abnormal development. Cogn Dev. 2000;15:1-16.
41. Sucksmith E, Allison C, Baron-Cohen S, Chakrabarti B, Hoekstra RA. Empathy and emotion recognition in people with autism, first-degree relatives, and controls. Neuropsychologia. 2013;51:98-105.
42. Palermo R, O'Connor KB, Davis JM, Irons J, McKone E. New tests to measure individual differences in matching and labelling facial expressions of emotion, and their association with ability to recognise vocal emotions and facial identity. PLoS One. 2013;8:e68126.
43. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400-3.
44. Klin A, Jones W, Schultz R, Volkmar F. The enactive mind, or from actions to cognition: lessons from autism. Philos Trans R Soc Lond B Biol Sci. 2003;358:345-60.
45. Chevallier C, Kohls G, Troiani V, Brodkin ES, Schultz RT. The social motivation theory of autism. Trends Cogn Sci. 2012;16:231-9.
46. Hill EL. Executive dysfunction in autism. Trends Cogn Sci. 2004;8:26-32.
47. Boyd BA, McBee M, Holtzclaw T, Baranek GT, Bodfish JW. Relationships among repetitive behaviors, sensory features, and executive functions in high functioning autism. Res Autism Spectr Disord. 2009;3:959-66.
48. Johnson MH. Executive function and developmental disorders: the flip side of the coin. Trends Cogn Sci. 2012;16:454-7.
49. Pugliese CE, Anthony L, Strang JF, Dudley K, Wallace GL, Kenworthy L. Increasing adaptive behavior skill deficits from childhood to adolescence in autism spectrum disorder: Role of Executive Function. J Autism Dev Disord. 2014;45(60):1579-87.
50. Sjowall D, Roth L, Lindqvist S, Thorell LB. Multiple deficits in ADHD: executive dysfunction, delay aversion, reaction time variability, and emotional deficits. J Child Psychol Psychiatry. 2013;54:619-27.
51. den Ouden HE, Daw ND, Fernandez G, Elshout JA, Rijpkema M, Hoogman M, Franke B, Cools R. Dissociable effects of dopamine and serotonin on reversal learning. Neuron. 2013;80:1090-100.
52. Happe F, Frith U. The weak coherence account: detail-focused cognitive style in autism spectrum disorders. J Autism Dev Disord. 2006;36:5-25.
53. Baron-Cohen S. Empathizing, systemizing, and the extreme male brain theory of autism. Prog Brain Res. 2010;186:167-75.
54. Baron-Cohen S, Richler J, Bisarya D, Gurunathan N, Wheelwright S. The systemizing quotient: an investigation of adults with Asperger syndrome or high-functioning autism, and normal sex differences. Philos Trans R Soc Lond B Biol Sci. 2003;358:361-74.
55. Loth E, Gomez JC, Happe F. Do high-functioning people with autism spectrum disorder spontaneously use event knowledge to selectively attend to and remember context-relevant aspects in scenes? J Autism Dev Disord. 2011;41:945-61.
56. Pellicano E, Burr D. When the world becomes 'too real': a Bayesian explanation of autistic perception. Trends Cogn Sci. 2012;16:504-10.
57. Summerfield C, Egner T, Greene M, Koechlin E, Mangels J, Hirsch J. Predictive codes for forthcoming perception in the frontal cortex. Science. 2006;314:1311-4.
58. Sinha P, Kjelgaard MM, Gandhi TK, Tsourides K, Cardinaux AL, Pantazis D, Diamond SP, Held RM. Autism as a disorder of prediction. Proc Natl Acad Sci U S A. 2014;111:15220-5.
59. Nystrom P, Gredeback G, Bolte S, Falck-Ytter T, team E. Hypersensitive pupillary light reflex in infants at risk for autism. Mol Autism. 2015;6:10.
60. Klin A, Shultz S, Jones W. Social visual engagement in infants and toddlers with autism: early developmental transitions and a model of pathogenesis. Neurosci Biobehav Rev. 2015;50:189-203.
61. Klin A, Jones W, Schultz R, Volkmar F, Cohen D. Visual fixation patterns during viewing of naturalistic social situations as predictors of social competence in individuals with autism. Arch Gen Psychiatry. 2002;59:809-16.
62. Putnam PT, Roman JM, Zimmerman PE, Gothard KM. Oxytocin enhances gaze-following responses to videos of natural social behavior in adult male rhesus monkeys. Psychoneuroendocrinology. 2016;72:47-53.
63. Depue RA, Morrone-Strupinsky JV. A neurobehavioral model of affiliative bonding: implications for conceptualizing a human trait of affiliation. Behav Brain Sci. 2005;3:313-50.
64. Daly EM, Deeley Q, Ecker C, Craig M, Hallahan B, Murphy C, Johnston P, Spain D, Gillan N, Brammer M, et al. Serotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletion. Arch Gen Psychiatry. 2012;69:1003-13.
65. Courchesne E, Campbell K, Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res. 2011;1380:138-45.
66. Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ. Autism and abnormal development of brain connectivity. J Neurosci. 2004;24:9228-31.
67. Ecker C, Bookheimer SY, Murphy DG. Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. Lancet Neurol. 2015;14:1121-34.
68. Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M, Jacobson K, Lyons MJ, Grant MD, Franz CE, et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex. 2009;19:2728-35.
69. Wierenga LM, Langen M, Oranje B, Durston S. Unique developmental trajectories of cortical thickness and surface area. Neuroimage. 2014;15:120-6.
70. Ecker C, Ronan L, Feng Y, Daly E, Murphy C, Ginestet CE, Brammer M, Fletcher PC, Bullmore ET, Suckling J, et al. Intrinsic gray-matter connectivity of the brain in adults with autism spectrum disorder. Proc Natl Acad Sci U S A. 2013;110:13222-7.
71. Catani M, Dell'Acqua F, Budisavljevic S, Howells H, Thiebaut de Schotten M, Froudist-Walsh S, D'Anna L, Thompson A, Sandrone S, Bullmore ET, et al. Frontal networks in adults with autism spectrum disorder. Brain. 2016;139:616-30.
72. Delmonte S, Balsters JH, McGrath J, Fitzgerald J, Brennan S, Fagan AJ, Gallagher L. Social and monetary reward processing in autism spectrum disorders. Mol Autism. 2012;3:7.
73. Castelli F, Frith C, Happe F, Frith U. Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain. 2002;125:1839-49.
74. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, Mattay VS, Egan M, Weinberger DR. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry. 2006;11:867-877, 797.
75. Plichta MM, Schwarz AJ, Grimm O, Morgen K, Mier D, Haddad L, Gerdes AB, Sauer C, Tost H, Esslinger C, et al. Test-retest reliability of evoked BOLD signals from a cognitive-emotive fMRI test battery. Neuroimage. 2012;60:1746-58.
76. Moessnang C, Schaefer A, Bilek E, Roux P, Otto K, Baumeister S, Hohmann S, Poustka L, Brandeis D, Banaschewski T, et al. Specificity, reliability and sensitivity of social brain responses during spontaneous mentalizing. Soc Cogn Affect Neurosci. 2016;11:1687-97.
77. Kundu P, Inati SJ, Evans JW, Luh WM, Bandettini PA. Differentiating BOLD and non-BOLD signals in fMRI time series using multi-echo EPI. Neuroimage. 2012;60:1759-70.
78. Lombardo MV, Auyeung B, Holt RJ, Waldman J, Ruigrok AN, Mooney N, Bullmore ET, Baron-Cohen S, Kundu P: Improving effect size estimation and statistical power with multi-echo fMRI and its impact on understanding the neural systems supporting mentalizing. Neuroimage. 2016;142:55-66.
79. Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage. 2012;59:2142-54.
80. Smith SM, Miller KL, Moeller S, Xu J, Auerbach EJ, Woolrich MW, Beckmann CF, Jenkinson M, Andersson J, Glasser MF, et al. Temporally-independent functional modes of spontaneous brain activity. Proc Natl Acad Sci U S A. 2012;109:3131-6.
81. Di Martino A, Yan CG, Li Q, Denio E, Castellanos FX, Alaerts K, Anderson JS, Assaf M, Bookheimer SY, Dapretto M, et al. The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism. Mol Psychiatry. 2014;19:659-67.
82. Hahamy A, Behrmann M, Malach R. The idiosyncratic brain: distortion of spontaneous connectivity patterns in autism spectrum disorder. Nat Neurosci. 2015;18:302-9.
83. Banaschewski T, Brandeis D. Annotation: what electrical brain activity tells us about brain function that other techniques cannot tell us - a child psychiatric perspective. J Child Psychol Psychiatry. 2007;48:415-35.
84. McPartland JC. Considerations in biomarker development for neurodevelopmental disorders. Curr Opin Neurol. 2016;29:118-22.
85. Webb SJ, Bernier R, Henderson HA, Johnson MH, Jones EJ, Lerner MD, McPartland JC, Nelson CA, Rojas DC, Townsend J, Westerfield M: Guidelines and best practices for electrophysiological data collection, analysis and reporting in autism. J Autism Dev Disord. 2013;45(2):425-43.
86. Buzsaki G, Wang XJ. Mechanisms of gamma oscillations. Annu Rev Neurosci. 2012;35:203-25.
87. Palmieri L, Persico AM. Mitochondrial dysfunction in autism spectrum disorders: cause or effect? Biochim Biophys Acta. 1797;2010:1130-7.
88. Schain RJ, Freedman DX. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr. 1961;58:315-20.
89. Gabriele S, Sacco R, Persico AM. Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2014;24:919-29.
90. McBride PA, Anderson GM, Hertzig ME, Snow ME, Thompson SM, Khait VD, Shapiro T, Cohen DJ. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry. 1998;37:767-76.
91. Patterson PH. Maternal infection and immune involvement in autism. Trends Mol Med. 2011;17:389-94.
92. Mandy W, Lai MC. Annual research review: the role of the environment in the developmental psychopathology of autism spectrum condition. J Child Psychol Psychiatry. 2016;57:271-92.
93. Estes ML, McAllister AK. Alterations in immune cells and mediators in the brain: it's not always neuroinflammation! Brain Pathol. 2014;24:623-30.
94. Baron-Cohen S, Auyeung B, Norgaard-Pedersen B, Hougaard DM, Abdallah MW, Melgaard L, Cohen AS, Chakrabarti B, Ruta L, Lombardo MV. Elevated fetal steroidogenic activity in autism. Mol Psychiatry. 2015;20:369-76.
95. Xiang AH, Wang X, Martinez MP, Walthall JC, Curry ES, Page K, Buchanan TA, Coleman KJ, Getahun D. Association of maternal diabetes with autism in offspring. JAMA. 2015;313:1425-34.
96. Moreno-de-Luca A, Myers SM, Challman TD, Moreno-de-Luca D, Evans DW, Ledbetter DH. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol. 2013;12:406-14.
97. Cocks G, Curran S, Gami P, Uwanogho D, Jeffries AR, Kathuria A, Lucchesi W, Wood V, Dixon R, Ogilvie C, et al. The utility of patient specific induced pluripotent stem cells for the modelling of autistic spectrum disorders. Psychopharmacology (Berl). 2014;231:1079-88.
98. Thomas MS, Annaz D, Ansari D, Scerif G, Jarrold C, Karmiloff-Smith A. Using developmental trajectories to understand developmental disorders. J Speech Lang Hear Res. 2009;52:336-58.
99. Ecker C, Murphy D. Neuroimaging in autism - from basic science to translational research. Nat Rev Neurol. 2014;10:82-91.
100. Wolfers T, Buitelaar JK, Beckmann CF, Franke B, Marquand AF. From estimating activation locality to predicting disorder: A review of pattern recognition for neuroimaging-based psychiatric diagnostics. Neurosci Biobehav Rev. 2015;57:328-49.
101. Ecker C, Marquand A, Mourao-Miranda J, Johnston P, Daly EM, Brammer MJ, Maltezos S, Murphy CM, Robertson D, Williams SC, Murphy DG. Describing the brain in autism in five dimensions - magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach. J Neurosci. 2010;30:10612-23.
102. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, et al. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010;9:560-74.
103. Lombardo MV, Lai M-C, Auyeung B, Holt RJ, Allison C, Smith P, Chakrabarti B, Ruigrok ANV, Suckling J, Bullmore E, et al. Unsupervised data-driven stratification of mentalizing heterogeneity in autism. Sci Rep. 2016;6:35333.
104. Campbell DJ, Shic F, Macari S, Chawarska K. Gaze response to dyadic bids at 2 years related to outcomes at 3 years in autism spectrum disorders: a subtyping analysis. J Autism Dev Disord. 2014;44:431-42.
105. Marquand AF, Rezek I, Buitelaar J, Beckmann CF. Understanding heterogeneity in clinical cohorts using normative models: beyond case-control studies. Biol Psychiatry. 2016;80:552-61.
106. Milne E, Scope A, Pascalis O, Buckley D, Makeig S. Independent component analysis reveals atypical electroencephalographic activity during visual perception in individuals with autism. Biol Psychiatry. 2009;65:22-30.
107. Jeste SS, Kirkham N, Senturk D, Hasenstab K, Sugar C, Kupelian C, Baker E, Sanders AJ, Shimizu C, Norona A, et al. Electrophysiological evidence of heterogeneity in visual statistical learning in young children with ASD. Dev Sci. 2015;18:90-105.
108. Hinrichs C, Singh V, Xu G, Johnson SC, Alzheimers Disease Neuroimaging I. Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. Neuroimage. 2011;55:574-89.
109. Hofree M, Shen JP, Carter H, Gross A, Ideker T. Network-based stratification of tumor mutations. Nat Methods. 2013;10:1108-15.
110. Fountain C, Winter AS, Bearman PS. Six developmental trajectories characterize children with autism. Pediatrics. 2012;129:e1112-1120.
111. Lee JW, Devanarayan V, Barrett YC, Weiner R, Allinson J, Fountain S, Keller S, Weinryb I, Green M, Duan L, et al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res. 2006;23:312-28.
112. Prata D, Mechelli A, Kapur S. Clinically meaningful biomarkers for psychosis: a systematic and quantitative review. Neurosci Biobehav Rev. 2014;45:134-41.
113. von Rhein D, Mennes M, van Ewijk H, Groenman AP, Zwiers MP, Oosterlaan J, Heslenfeld D, Franke B, Hoekstra PJ, Faraone SV, et al. The NeuroIMAGE study: a prospective phenotypic, cognitive, genetic and MRI study in children with attention-deficit/hyperactivity disorder. Design and descriptives. Eur Child Adolesc Psychiatry. 2014;24(3):265-81.
114. Scott-Van Zeeland AA, Dapretto M, Ghahremani DG, Poldrack RA, Bookheimer SY. Reward processing in autism. Autism Res. 2010;3:53-67.
115. Ring HA, Baron-Cohen S, Wheelwright S, Williams SC, Brammer M, Andrew C, Bullmore ET. Cerebral correlates of preserved cognitive skills in autism: a functional MRI study of embedded figures task performance. Brain. 1999;122(Pt 7):1305-15.
116. Miller GA, Chapman JP. Misunderstanding analysis of covariance. J Abnorm Psychol. 2001;110:40-8.
117. Novack GD. The CONSORT statement for publication of controlled clinical trials. Ocul Surf. 2004;2:45-6.